Am I a Candidate for IVF? Signs You Should Consider IVF Treatment with Monash IVF KPJ Johor in Malaysia.

Many couples in Malaysia ask a version of the same question when fertility challenges arise: is IVF actually the right treatment for our situation, or is there something else we should explore first? Most people already understand the basic concept of in vitro fertilisation. The harder part is knowing whether their specific circumstances genuinely call for it.

Fertility decisions are shaped by a combination of factors, including medical history, age, underlying conditions, and previous treatment outcomes. Knowing what makes IVF the appropriate recommendation, and how it compares to other options, is how couples move from months of uncertainty to a clear, specialist-guided plan.

Key Takeaways

• IVF is not the default first step. It is recommended when specific conditions have not responded to less invasive options.
• Blocked fallopian tubes, severe male factor infertility, endometriosis, unexplained infertility after failed IUI, and PCOS that has not responded to ovulation induction are among the most common clinical indications.
• Age matters significantly. Women over 35 may be recommended for IVF sooner, as egg quality and ovarian reserve decline with age.
• IVF can be combined with ICSI for male factor cases and with PGT-A for couples with a history of recurrent miscarriage or known genetic concerns.
• A first consultation is a clinical assessment, not a commitment to proceed with IVF.

What Is IVF and Who Is It For?

In vitro fertilisation (IVF) is a procedure in which eggs are retrieved from a woman’s ovaries and fertilised with sperm in a laboratory setting. The fertilised eggs develop into embryos, which are then transferred to the uterus. Pregnancy begins if implantation is successful.

IVF is a targeted treatment designed to address specific barriers to conception. It is not the default starting point for every couple facing fertility challenges. A fertility specialist will assess your complete health profile, including hormonal indicators, reproductive anatomy, sperm quality, and treatment history, to determine whether in vitro fertilisation is the most appropriate pathway for you.

Infertility is also more common than most people realise. The World Health Organization’s 2023 report found that around 17.5% of adults worldwide, roughly 1 in 6 people, experience it at some point in their lives, with rates fairly consistent across both high-income and lower-income regions.

Medical Conditions That Make IVF a Suitable Option

A fertility specialist may recommend IVF when tests identify a barrier that makes natural conception or less invasive treatment more difficult. The most common indications are outlined below.

Blocked or Damaged Fallopian Tubes

If one or both fallopian tubes are blocked or severely damaged, sperm cannot reach the egg through natural fertilisation. IVF bypasses the tubes entirely by retrieving eggs directly from the ovaries and fertilising them in the laboratory. It is one of the most clearly indicated treatments for this condition.

Male Factor Infertility

Low sperm count, poor sperm motility, or abnormal morphology significantly reduces the likelihood of natural fertilisation. In these cases, IVF is often performed alongside ICSI (intracytoplasmic sperm injection), a technique in which a single sperm is injected directly into the egg to improve fertilisation precision.

Unexplained Infertility

Some couples receive test results within normal range, yet natural conception has not occurred after an appropriate period of trying. IVF may be recommended after first-line treatments have not succeeded, as it allows specialists to closely monitor fertilisation and early embryo development in a controlled setting.

Polycystic Ovary Syndrome (PCOS) and Ovulation Disorders

Polycystic ovary syndrome, recently renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) following a multistep global expert consensus published in The Lancet, is the most common hormonal disorder in women of reproductive age. 

The World Health Organization estimates it affects 10 to 13 percent of women globally, making it a leading cause of ovulatory infertility, with up to 70 percent of cases going undiagnosed.

PCOS/PMOS disrupts regular egg release, making natural conception unpredictable. IVF may become the appropriate next step if ovulation-stimulating medications or IUI cycles have not achieved results.

Endometriosis

Endometriosis can damage the fallopian tubes, affect ovarian function, and alter the uterine environment in ways that reduce fertility. IVF allows specialists to work around many of the physical obstacles this condition creates.

Previous Failed IUI Cycles

Intrauterine insemination (IUI) is a less invasive first-line option suited to certain cases. If multiple IUI cycles have not resulted in pregnancy, IVF may be considered after unsuccessful IUI cycles, depending on your age, diagnosis and previous treatment.
Each of these conditions creates a different type of barrier to conception. IVF is specifically designed to address them, either by bypassing anatomical obstacles or by improving the precision of fertilisation and embryo development.

When Age Becomes a Factor in Considering IVF

Age is one of the most clinically significant variables in fertility planning. A woman’s egg quality and quantity decline gradually from her mid-30s onward, and this directly affects both the likelihood of natural conception and IVF outcomes.

Fertility specialists often use the following as a general framework:

Age Group	General Guideline
Under 35	Try naturally for 12 months before seeking specialist review
35 to 37	Seek specialist review after 6 months
38 and above	Earlier specialist assessment is recommended

Couples with a known medical condition or identifiable fertility concern do not need to wait for any specific period before seeking specialist review.

How Age Affects IVF Outcomes

The relationship between maternal age and IVF success is among the most thoroughly documented areas in reproductive medicine.

Age-related decline in IVF outcomes does not mean the treatment is unavailable for older patients. Speaking with a specialist sooner may help you understand the options available.

“Am I Too Old for IVF?”

Some women in their late 30s have strong ovarian reserve; others in their early 30s do not. Research documents that a woman’s available egg reserve falls to approximately 25,000 by age 37 and around 1,000 by the average age of menopause, and AMH levels begin declining from approximately age 25 onwards.

A fertility assessment that includes an AMH (anti-Müllerian hormone) blood test and antral follicle count can help assess ovarian reserve and are interpreted alongside age, medical history and other findings.

IVF or IUI: How Do You Know Which Treatment Is Right?

IUI and IVF are both fertility treatments, but they work through different mechanisms and suit different clinical situations. Understanding the difference can help you ask more informed questions during your consultation.

Differences between IUI and IVF

Feature	IUI (Intrauterine Insemination)	IVF (In Vitro Fertilisation)
How it works	Prepared sperm placed directly into the uterus; fertilisation occurs naturally inside the body	Eggs retrieved from ovaries and fertilised in the laboratory; embryo transferred to uterus
Invasiveness	Minimally invasive; no sedation required	More involved; egg retrieval requires sedation
Cost	Lower cost per cycle	Higher cost; varies by treatment plan and additional procedures (e.g. PIEZO, PGT)
Best suited for	Mild male factor infertility, open tubes, ovulation disorders, unexplained infertility in younger women	Blocked tubes, significant male factor infertility, failed IUI cycles, complex or age-related cases
Success rate per cycle	Lower	Higher in indicated cases
Genetic testing of embryos	Not applicable	Available (PGT), where clinically indicated

How a Specialist Makes the Recommendation

A fertility specialist will consider the following when determining which treatment is appropriate:

1. The underlying cause of infertility
2. The couple’s age and treatment timeline
3. Previous treatment history, including prior IUI outcomes

IVF is not always the first step, and IUI is not always a sufficient one. The recommendation is always specific to your clinical profile. In vitro fertilisation costs in Malaysia vary depending on the treatment plan, medications required, and any additional procedures. A consultation with an IVF specialist in Monash IVF KPJ Johor will clarify what the full procedure involves and what costs apply to your specific case.

What to Do If You Think IVF Might Be Right for You

Recognising that IVF may be relevant to your situation is the first step. The practical next move is a consultation with a fertility specialist, which gives you a personalised assessment and a clear picture of whether in vitro fertilisation is the most appropriate pathway for your profile.

A first consultation at a fertility centre in Malaysia normally covers:

• A review of your medical history and any prior test results
• Hormone blood tests to assess ovarian reserve, including AMH
• A pelvic ultrasound to assess antral follicle count
• Semen analysis to assess sperm quality, if not already completed
• A discussion of your conception history and fertility timeline
• A specialist’s recommendation on the most suitable treatment pathway

Malaysia recorded just 414,918 births in 2024, the lowest since 1980 and a 9% drop from the year before, BERNAMA reported. In response, the government expanded its national BuAI programme, aiming to help 30,000 couples get subsidised fertility treatment.

At Monash IVF KPJ Johor, our fertility specialists bring over 20years of clinical experience to every consultation. As a hospital-based, RTAC-certified centre, we provide a thorough assessment of your fertility profile and evidence-based guidance on whether IVF, IUI, or another treatment pathway is the right next step for you.

Take the Next Step today. Speak to an IVF Specialist at Monash IVF KPJ Johor. 

Citations and References

BERNAMA. (2025). Gov’t Targets 30,000 Couples To Benefit From Fertility Treatment Aid. Available at: https://www.bernama.com/en/general/news.php?id=2481566

World Health Organization. (2023). 1 in 6 people globally affected by infertility: WHO. Available at: https://www.who.int/news/item/04-04-2023-1-in-6-people-globally-affected-by-infertility 

Teede, H., Khomami, M., Morman, R., et al.. (2026). Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Available at: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00717-8/fulltext 

World Health Organization. (2026). Polycystic ovary syndrome. Available at: https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome 

Carlson, K. & Sparzak, P.B. (2026). Age-Related Fertility Decline. StatPearls. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK576440/ 

FAQs about IVF Treatment in Malaysia

Who is a good candidate for IVF treatment?

Good candidates for IVF have blocked or damaged fallopian tubes, significant male factor infertility such as low sperm count or poor motility, unexplained infertility after failed first-line treatments, ovulation disorders such as PCOS/PMOS, endometriosis affecting reproductive function, or a history of failed IUI cycles. Women aged 35 and above are advised to seek specialist assessment earlier than younger patients.

What is the difference between IVF and IUI?

IUI places prepared sperm directly into the uterus and allows fertilisation to occur naturally inside the body; IVF retrieves eggs from the ovaries, fertilises them in a laboratory, and transfers the resulting embryo to the uterus. IUI is less invasive and lower in cost, suited to milder fertility challenges with open tubes. IVF is recommended for blocked tubes, significant male factor infertility, or when IUI has not achieved results.

At what age should you consider IVF?

Women under 35 are generally advised to try naturally for 12 months before seeking specialist review; women aged 35 to 37 should seek review after 6 months; women aged 38 and above are advised to seek assessment quickly. Age directly affects IVF success rates, but an AMH blood test gives a more accurate measure of individual reproductive potential than age alone.